# Intensive Value Utilization of Food‐Derived Marine Immunoactive Peptides: Optimizing the Process Yield and Improving the Delivery Efficiency According to the Immune Activity Mechanism and Assisted Enzymatic Hydrolysis

**Authors:** Zhicheng Yin, Yingying Tian, Shuteng Huang, Hong Wang, Lili Zhao, Ruyue Zhang, Desheng Cai, Shuping Wang, Shaojing Zhong, Jiayu Zhang

PMC · DOI: 10.1002/fsn3.70578 · 2025-08-05

## TL;DR

This paper explores how to improve the absorption and effectiveness of marine peptides used in food products to boost immunity and gut health.

## Contribution

The paper introduces a novel approach combining assisted enzymatic hydrolysis and peptide self-assembly to enhance the delivery and stability of marine immunoactive peptides.

## Key findings

- Assisted enzymatic hydrolysis improves protein yield and biological activity of marine peptides.
- Peptide-derived hydrogels enhance retention and absorption in the gastrointestinal tract.
- Immunoactive peptides can modulate intestinal flora and support immune function.

## Abstract

Food‐borne marine active peptides have been increasingly used as functional products for postoperative rehabilitation. However, there are still many problems, such as low protein yield and absorption rate. Therefore, the assisted enzymatic hydrolysis process and activity of marine immunoreactive peptides have been the focus of widespread attention. In particular, they are used as natural immunomodulators to improve intestinal microbiota and immune damage. Most peptides are barely digested by the gastrointestinal tract, especially in the immune microenvironment‐damaged intestine. How to make the damaged intestine fully absorb active substances has become an urgent problem to be solved in food distribution. Therefore, the optimization process method is summarized to improve the quality and efficiency, and according to the immune activity mechanism combined with peptide self‐assembly food application, which provides an alternative for the design of functional products. Sustained release of peptide‐derived hydrogels increases their retention time in the body and promotes complete absorption in the gastrointestinal tract. By targeting release and enhancing biologically active functions, peptides avoid enzymatic hydrolysis in the gastrointestinal tract, thereby improving the stability of food‐derived immunoactive peptide delivery. Moreover, with the increasing correlation between food‐borne products and intestinal flora, the active sites of food‐borne immunoactive peptides and metal ion chelating peptides are more conducive to the micro‐regulation of intestinal flora. This review provides an opportunity for food and drug applications and development related to immunotherapy.

To investigate the impact of assisted enzymatic hydrolysis on enhancing protein yield and biological activity. The analysis of the potential mechanism of intestinal immune regulation mediated by intestinal microorganisms is conducted. This article provides a review of the potential uses of functional, immunoactive peptides in food delivery and offers valuable insights for forthcoming product development and utilization.

## Full-text entities

- **Genes:** Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, HO-1 [NCBI Gene 101214191], Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}
- **Diseases:** autoimmune diseases (MESH:D001327), dysbacteriosis (MESH:D064806), hyperuricemia (MESH:D033461), Fatigue (MESH:D005221), ulcerative colitis (MESH:D003093), immunodeficiency (MESH:D007153), intestinal diseases (MESH:D007410), chronic diseases (MESH:D002908), organ damage (MESH:D000092124), kidney inflammation (MESH:D007674), osteoporosis (MESH:D010024), ALI (MESH:D017114), toxicity (MESH:D064420), mucosal injury (MESH:D052016), Arthropod Gate (MESH:D004671), IBD (MESH:D015212), Immune injury diseases (MESH:D007154), intestinal cancer diseases (MESH:D007414), blood syndrome (MESH:D006402), infection (MESH:D007239), inflammation (MESH:D007249), cancer (MESH:D009369), flora disorder (MESH:D009358)
- **Chemicals:** Zn (MESH:D015032), Glutamic acid (MESH:D018698), propionate (MESH:D011422), ester (MESH:D004952), hydroxyproline (MESH:D006909), thiol (MESH:D013438), SCFAs (MESH:D005232), AMP (MESH:D000249), Ca (MESH:D002118), oligopeptide (MESH:D009842), BCFAs (-), indolepropionic acid (MESH:C015292), alanine (MESH:D000409), carbon (MESH:D002244), threonine (MESH:D013912), methionine (MESH:D008715), cyclophosphamide (MESH:D003520), essential amino acids (MESH:D000601), hydrazone (MESH:D006835), Glycine (MESH:D005998), Metal (MESH:D008670), aspartic acid (MESH:D001224), LPS (MESH:D008070), tyrosine (MESH:D014443), lysine (MESH:D008239), aldehyde (MESH:D000447), hydrogen (MESH:D006859), histidine (MESH:D006639), Butyrate (MESH:D002087), Butyric acid (MESH:D020148), acetate (MESH:D000085), bile acids (MESH:D001647), fatty acid (MESH:D005227), acetic acid (MESH:D019342), water (MESH:D014867), lactic acid (MESH:D019344), Amino Acid (MESH:D000596), proline (MESH:D011392), amide (MESH:D000577)
- **Species:** Bacteroides (genus) [taxon 816], Pandalus borealis (northern red shrimp, species) [taxon 6703], gut metagenome (species) [taxon 749906], Euphausiacea (krill, order) [taxon 6816], Penaeus vannamei (Pacific white shrimp, species) [taxon 6689], Lactococcus (lactic streptococci, genus) [taxon 1357], Enterobacter (genus) [taxon 547], Bifidobacterium (genus) [taxon 1678], Homo sapiens (human, species) [taxon 9606], Scombridae gen. sp. (tuna, species) [taxon 8233], Lactobacillus acidophilus (species) [taxon 1579], Oryza sativa (Asian cultivated rice, species) [taxon 4530], Ganoderma lucidum (species) [taxon 5315], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Ostreidae (oysters, family) [taxon 6563], Mus musculus (house mouse, species) [taxon 10090], catfish (species) [taxon 71179], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Actinopterygii (fishes, superclass) [taxon 7898]
- **Mutations:** Ser360Ala, C   50 C, C   60 C
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12322830/full.md

---
Source: https://tomesphere.com/paper/PMC12322830